NEW YORK, Oct. 31, 2016 -- WisdomTree Commodity Services LLC (“WCS”), in its capacity as the managing owner and commodity pool operator of WisdomTree Continuous Commodity Index Fund (NYSE:GCC), has resumed the ability of Authorized Participants to purchase new Creation Baskets in shares of GCC.
It is possible that the market value of GCC’s shares may be affected by the resumption of issuance of shares of GCC, and the market value may be higher or lower than the intra-day indicative value of the shares and/or the net asset value of the shares.
Any forward-looking statements herein are based on the expectations of WCS and GCC at this time. Whether or not actual results and developments will conform to WCS's or GCC’s expectations and predictions, however, is subject to a number of risks and uncertainties, including the general economic, market and business conditions, changes in laws or regulations or other actions made by governmental authorities or regulatory bodies, and other world economic and political developments. WCS and GCC undertake no duty to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
About WisdomTree
WisdomTree Investments, Inc., through its subsidiaries in the U.S., Europe, Japan and Canada (collectively, “WisdomTree”), is an exchange-traded fund (“ETF”) and exchange-traded product (“ETP”) sponsor and asset manager headquartered in New York. WisdomTree offers products covering equities, fixed income, currencies, commodities and alternative strategies. WisdomTree currently has approximately $38.8 billion in assets under management globally.
WisdomTree® is the marketing name for WisdomTree Investments, Inc. and its subsidiaries worldwide.
Contact: Media Relations WisdomTree Investments, Inc. Jessica Zaloom / Melissa Chiles +1.917.267.3735 / +1.917.267.3797 [email protected] / [email protected] Investor Relations WisdomTree Investments, Inc. Jason Weyeneth, CFA +1.917.267.3858 [email protected]


FDA Approves Mitapivat for Anemia in Thalassemia Patients
Italy Fines Apple €98.6 Million Over App Store Dominance
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue 



